Cellvizio® is the real-time in vivo cellular imaging platform that revolutionizes the way physicians diagnose and treat patients.
Boston, MA
Joined March 2011
- Tweets2.2K
- Following1.9K
- Followers1.2K
- Likes910
Conventional tests only detect IgE allergies, leaving #IBS food triggers undetected.
@CCAD now offers @CellTolerance powered by #Cellvizio, visualizing non-IgE mucosal reactions in real time to guide targeted diets.
Read in full: hubs.la/Q04Dsp2c0
$ALMKT #GITwitter
On @MedicalBriefs podcast, Dr. Anjuli Luthra breaks down how #Cellvizio transforms patient management by:
- Preventing life-altering, unnecessary surgeries
- Identifying high-grade dysplasia that standard care misses
hubs.la/Q04Drz5t0
#PancreaticCysts #GITwitter
Congratulations to @BAPanugantiMD & team at @BarnesJewish on already reaching 50+ #Cellvizio cases! More than a number: 50+ patients have benefited from Cellvizio, leading to better margins, more confident decisions, & optimized outcomes.
#Lungcancer is the world’s leading cause of cancer deaths, and its diagnosis remains challenging. Our mission is to empower physicians to achieve an earlier, more definitive diagnosis.
Learn how Cellvizio advanced imaging improves diagnostic accuracy: hubs.la/Q04D5RQy0
Cellvizio® by Mauna Kea Technologies retweeted
We are proud to introduce a new approach to diagnosing food intolerance in patients with chronic, unexplained gastrointestinal symptoms.
Using advanced endo-microscopy, physicians can observe cellular reactions in the small intestine in real time after introducing specific food particles, helping identify potential food intolerances and guide more personalized dietary recommendations.
For patients living with persistent bloating, diarrhea, abdominal pain and digestive discomfort, this innovative approach can bring greater clarity and a more targeting path to care.
Cellvizio® by Mauna Kea Technologies retweeted
A closer look at real-time cellular food intolerance testing.
We are proud to introduce a new way to identify potential food intolerances in the MENA region for patients with chronic, unexplained gastrointestinal symptoms.
Using advanced endo-microscopy, physicians can observe how the small intestine reacts to specific food particles in real time, helping identify potential food intolerances and guide more personalized dietary recommendations.
For patients experiencing persistent bloating, diarrhea, abdominal pain and digestive discomfort, this innovative approach can provide greater clarity and support a more targeted path to care.
When diagnosing #BarrettsEsophagus or evaluating #pancreaticcysts, relying on surface views or indirect markers may not be enough. "Cellvizio gives me a lot more knowledge when I do an endoscopy." -Kamran Ayub, MD, MRCP, FASGE
hubs.la/Q04yggk_0
#GITwitter
After years of unexplained gut symptoms, the @CellTolerance test gave Anna clarity. By revealing a primary barrier dysfunction, it allowed her to stop guessing, safely reintroduce foods, and restore her quality of life. Explore targeted GI care: hubs.la/Q04CcxdB0
#Cellvizio supports physicians across a broad range of clinical indications. Improve risk-stratification for pancreatic cysts. Increase Barrett's Esophagus detection. Help characterize lung nodules. All through real-time, in vivo cellular imaging. hubs.la/Q04BVVwh0
Thank you to the global #GI community who joined us in Barcelona! Incredible sessions from @RKiesslich, Prof. Detlef Schuppan, and Prof. Jost Langhorst sparked valuable discussions on advancing targeted care in patients who struggle with food-related symptoms. #GITwitter
Heading to Barcelona for #UEGWeek 2026? Let's connect! We'd love to discuss how @CellTolerance can support your patients struggling with chronic food-related digestive symptoms. Drop a message or comment to grab a coffee & chat during the event. Look forward to seeing you there!
Prof. Dr. med. Jost Langhorst explains the clinical turning point that led him to integrate @CellTolerance into his department.
Facing patient after patient with persistent digestive distress, surface-level management was no longer enough. hubs.la/Q04BgXrm0
#GITwitter
#Lungcancer often begins as small nodules making early & accurate diagnosis crucial for improving treatment outcomes & increasing survival rates.
Learn how the team at @CHRU_de_Nancy is leveraging #Cellvizio's clinical value: hubs.ly/Q04B0KDD0
#HealthyLungMonth
Early diagnosis of lung nodules enables timely surgery & avoids unnecessary procedures. For #HealthyLungMonth, learn how Cellvizio captures images from inside a lung lesion in real time, in vivo, providing the advantage of unique visibility & information:
hubs.la/Q04zND-B0
Prof. Jost Langhorst, MD captures a visible, real-time change on the intestinal surface during the @CellTolerance powered by #Cellvizio test.
See the complete procedure in action: hubs.la/Q04ymK9V0
Leading #GI specialists came together at Clinique Paris-Bercy to witness how @CellTolerance powered by #Cellvizio, is redefining care for patients with complex food-related symptoms. Watch Dr. Cavicchi's full interview: hubs.la/Q04yWlh50
#GITwitter
Stakes for #earlydetection have never been higher. The challenge isn't just finding visible lesions, it’s spotting flat, hidden dysplasia before it progresses. "Any patient with Barrett's is a good candidate for Cellvizio." -Kamran Ayub, MD, MRCP, FASGE
hubs.la/Q04yffXm0
We’re heading to DC for the 2026 @ForegutSociety Annual Meeting! As a proud exhibitor, we’re looking forward to connecting with specialists, sharing the latest clinical data, & joining the conversations driving what’s next in foregut care. Stop by & say hello at Booth 7.
#AFS2026
For millions suffering from food-related symptoms, @CellTolerance powered by #Cellvizio offers a new path to elevate daily quality of life. What does this breakthrough mean for patient care? Dr. Maryan Cavicchi (Clinique Paris-Bercy) weighs in: hubs.la/Q04y2l5x0
#GITwitter
.@ESGE_news recommends #Cellvizio for enhancing pancreatic cyst diagnosis, advancing its commercial adoption. A major step towards improving diagnostic accuracy and reducing unnecessary surgeries for patients worldwide!
hubs.la/Q04xM_nW0
#GITwitter #PancreaticCysts